Luoxin Pharmaceuticals Group Stock (002793.SZ) announced that its subsidiary Shandong Luoxin Lekang Pharmaceutical Co., Ltd. ("Luoxin Lekang") has recently received the approved and issued drug supplementary application approval notice of Montmorillonite Powder. In the review, the specifications of 1g and 2g of the product are considered to have passed the consistency evaluation of generic drug quality and efficacy, while the specification of 3g has passed the consistency evaluation of generic drug quality and efficacy.
According to reports, Montmorillonite Powder is a natural montmorillonite particle powder with a layered structure and non-uniform charge distribution. It has a strong fixing and inhibiting effect on viruses, bacteria and toxins, gases, etc. in the digestive tract, making them lose their pathogenic effects. In addition, it also has a strong covering and protective ability on the digestive tract mucosa, repairs and enhances the mucosal barrier's defense function against attack factors, and has the effect of balancing the normal bacterial flora and local pain relief. It is used for adult acute and chronic diarrhea and children's acute diarrhea.
It is recommended to use your Futubull account.
